TopFunds

Cencora

NYSE: COR

Stock price

308.78 USD

(+150.09%) 5 years

Health Care DistributorsMedical - Distribution

Insider Transactions

5Y price score: 206
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +150.09%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
16-sep.-26Sale(1,280)321.3(411,264)17,128GREENBERG LON Rdirectorlink
01-sep.-26Sale(985)326.0(321,080)16,169Krikorian Lazarusofficer: SVP & Chief Accounting Officerlink
24-aug.-26Sale(11,300)324.1(3,662,663)19,455Campbell Elizabeth Sofficer: Executive Vice Presidentlink
31-jul.-26Award113311.335,18113,188NALLY DENNIS Mdirectorlink
31-jul.-26Award97311.330,200893Cooper Ellendirectorlink
31-jul.-26Award97311.330,2004,456Tyler Lauren Mdirectorlink
30-jun.-26Award58240.514,00023,624Battaglia Silvanaofficer: Executive Vice Presidentlink
30-jun.-26Award50240.512,00030,756Campbell Elizabeth Sofficer: Executive Vice Presidentlink
29-jun.-26Award21,304--21,304Boratto Eva Cofficer: Chief Financial Officerlink
22-jun.-26Purchase550270.2148,6274,359Tyler Lauren Mdirectorlink

244.8

52-week range

377.5

308.78

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

6.8 %

Dividend Yield TTM

0.8 %

Market cap $

$ 60,077

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

22.9

Price / Book TTM

19.5

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

4

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

6.9 %

160.1 %

294.5 %

Free cash flow per share growth

3,404.2 %

83.1 %

(3) %

Earnings per share growth

11.9 %

148 %

1,383.9 %

Dividends

Previous dividend:0.60 per share, Paid, Ex-div date Aug 14, 2026

Analyst ratings

Price Target Low

330

Price Target High

430

Price Target Median

350

Buy

33

Hold

12

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
(0.6)
6.3
1.6
7.5
4
(16.6)
7.4
8
8.5
7.5
8
-
6.4
7.1
7.8
8.6
9.5
9.9
02FCF per share
16.9
12
4.6
4.9
9.6
9
10.7
10.4
16.9
15
16.4
(0.3)%
21.9
24
26.3
28.9
31.7
32.5
03Dividends per share
Help
Adjusted for splitsLearn more
1.6
1.4
2.4
2.6
2.8
1.7
3
3.1
1.9
2
2.2
3.4%
-
-
-
-
-
-
04Dividends payout, %
(188.3)%
20.2%
77.3%
20.1%
39.6%
(10.1)%
23.8%
23.1%
22.9%
27.6%
28.1%
-
-
-
-
-
-
-
05Revenue
$ 135,962
$ 146,850
$ 153,144
$ 167,940
$ 179,589
$ 189,894
$ 213,989
$ 238,587
$ 262,173
$ 293,959
$ 321,333
9%
$ 350,194
$ 381,648
$ 415,926
$ 453,284
$ 493,997
$ 508,817
06ㅤ% Change
-
8%
4.3%
9.7%
6.9%
5.7%
12.7%
11.5%
9.9%
12.1%
9.3%
9%
9%
9%
9%
9%
9%
9%
07Net Income
(134.9)
1,428
414.5
1,658
855.4
(3,400)
1,540
1,699
1,745
1,509
1,554
-
1,245
1,357
1,479
1,612
1,757
1,809
08ㅤ% Margin
(0.1)%
1%
0.3%
1%
0.5%
(1.8)%
0.7%
0.7%
0.7%
0.5%
0.5%
0.4% A
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
09CFO
3,920
3,179
1,489
1,411
2,344
2,207
2,667
2,703
3,911
3,485
3,875
(0.1)%
4,963
5,409
5,895
6,424
7,002
7,212
10ㅤ% Of revenue
2.9%
2.2%
1%
0.8%
1.3%
1.2%
1.3%
1.1%
1.5%
1.2%
1.2%
1.4% A
1.4%
1.4%
1.4%
1.4%
1.4%
1.4%
11CAPEX
(231.6)
(464.6)
(466.4)
(336.4)
(310.2)
(369.7)
(438.2)
(496.3)
(458.4)
(487.2)
(668)
11.2%
(742.6)
(825.6)
(917.9)
(1,020)
(1,135)
(1,261)
12ㅤ% Change
-
100.6%
0.4%
(27.9)%
(7.8)%
19.2%
18.5%
13.3%
(7.7)%
6.3%
37.1%
11.2% A
11.2%
11.2%
11.2%
11.2%
11.2%
11.2%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
3,689
2,714
1,023
1,075
2,034
1,837
2,228
2,207
3,453
2,998
3,207
(1.4)%
4,221
4,584
4,977
5,404
5,867
5,950
14Total assets
27,736
33,590
35,317
37,670
39,172
44,275
57,338
56,561
62,559
67,102
76,590
10.7%
84,778
93,842
103,875
114,980
127,273
140,880
15ㅤ% Change
-
21.1%
5.1%
6.7%
4%
13%
29.5%
(1.4)%
10.6%
7.3%
14.1%
10.7%
10.7%
10.7%
10.7%
10.7%
10.7%
10.7%
16Total liabilities
27,347
31,508
33,252
34,968
36,466
45,115
56,753
56,489
61,893
66,315
74,843
10.6%
82,845
91,702
101,505
112,358
124,370
137,666
17ㅤ% Of assets
98.6%
93.8%
94.2%
92.8%
93.1%
101.9%
99%
99.9%
98.9%
98.8%
97.7%
97.7% A
97.7%
97.7%
97.7%
97.7%
97.7%
97.7%
18Shareholders Equity
389.6
2,082
2,065
2,702
2,706
(839.6)
584.4
71.3
666.3
786.7
1,747
16.2%
1,934
2,141
2,370
2,623
2,903
3,214
19Net Debt
1,572
1,721
1,359
2,170
1,119
385.4
6,204
4,056
4,129
3,422
6,353
15%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
217,786
225,959
221,602
220,336
211,840
204,783
208,465
211,210
204,591
200,284
195,214
(1.1)%
193,090
190,989
188,910
186,854
184,821
182,810
21ㅤ% Change
-
3.8%
(1.9)%
(0.6)%
(3.9)%
(3.3)%
1.8%
1.3%
(3.1)%
(2.1)%
(2.5)%
(1.1)%
(1.1)%
(1.1)%
(1.1)%
(1.1)%
(1.1)%
(1.1)%
22ROA
(0.5)%
4.3%
1.2%
4.4%
2.2%
(7.7)%
2.7%
3%
2.8%
2.3%
2%
-
1.5%
1.5%
1.4%
1.4%
1.4%
1.3%
23ROE
(34.6)%
68.6%
20.1%
61.4%
31.6%
404.9%
263.5%
2,383.5%
261.9%
191.8%
89%
-
64.4%
63.4%
62.4%
61.5%
60.5%
56.3%
24Interest coverage
11.7
11.7
13.5
8.7
9.5
12.8
14.7
11.9
8.9
12.2
8.7
-
-
-
-
-
-
-
25Dividend Yield
1.2%
1.7%
1.8%
1.7%
2%
1.7%
1.5%
1.4%
1.1%
0.9%
0.7%
-
-
-
-
-
-
-
26P/E Ratio
(153.2)
12
49.6
12.2
20.2
(5.8)
16
16.6
20.9
29.6
39
-
-
-
-
-
-
-
27Stock price range
75-115
74-105
69-96
73-105
71-94
74-105
95-126
114-166
137-193
179-248
220-313
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
20,688
17,142
18,071
20,216
17,303
19,848
24,597
28,213
36,820
44,679
60,575
11.3%
65,365
72,513
80,376
89,025
98,539
-
29FCF Yield
17.8%
15.8%
5.7%
5.3%
11.8%
9.3%
9.1%
7.8%
9.4%
6.7%
5.3%
(11.4)%
6.5%
6.3%
6.2%
6.1%
6%
-
30Average stock price
95.3
89.3
82.7
89.4
82.3
89.3
110.2
139.9
165.4
213.3
266
10.8%
338.5
379.7
425.5
476.4
533.2
-
31 CEO
RM
Robert Mauch